A frequent concern when taking oral ketoconazole is liver damage [1]. Patients and healthcare providers monitor for signs of hepatotoxicity, such as jaundice, dark urine, or abdominal pain [1].
How is liver damage from ketoconazole monitored?
Monitoring typically involves regular liver function tests to detect any abnormalities early [1]. If liver issues are suspected, treatment with oral ketoconazole may be discontinued [1].
What are the alternatives to oral ketoconazole for fungal infections?
For superficial fungal infections, topical formulations of ketoconazole are often preferred to minimize systemic exposure and reduce the risk of liver damage [2]. Other antifungal medications, including itraconazole or fluconazole, may be considered depending on the type and severity of the infection and patient-specific factors [3].
When is oral ketoconazole still prescribed?
Oral ketoconazole is generally reserved for severe fungal infections that have not responded to other treatments [4]. Its use is carefully weighed against the potential risks, particularly liver toxicity [4]. It is also used for specific conditions like Cushing's syndrome due to its ability to inhibit cortisol production [5].
What is the patent status of ketoconazole?
Ketoconazole is an older drug, and its primary patents have long expired, making it available as a generic medication [6]. DrugPatentWatch.com tracks patent and exclusivity data for pharmaceuticals [7].